Skip to content

A clinical trial of passive music therapy in the cognitive rehabilitation of stroke patients

A clinical trial of passive music therapy in the cognitive rehabilitation of stroke patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021484
Enrollment
Unknown
Registered
2019-02-23
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Treatment group:Music listening
Control group:Treatment as usual

Sponsors

The First Affiliated Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50-75 years; 2. Being within one week after having been administered an MRI scan and been diagnosed ischemic stroke on any of both hemispheres supplied by the middle cerebral artery; 3. MMSE >= 20 points; 4. Not having previous mental disorders or misuse of drugs or alcohol; 5. Not suffering from a serious hearing impairment; 6. Being right-handed; 7. Being willing to communicate and cooperate, and being able to speak Mandarin; 8. Having a music player; 9. Having a caregiver, and being able to commit with the intervention plan and to come to the hospital for the appointments; 10. Being themselves conscious of their condition or having relative aware of the patient's condition, and being willing to undertake the treatment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Suffering from any other cognitive disabilities or dementia such as impaired consciousness, neurological disorders caused by dementia (e.g., Alzheimer's disease), or any systematic diseases caused by it, and mental disorders like depression; 2. Having a coma, severe aphasia or hearing disability; 3. Suffering from severe depression (HAMD >= 7 points) which could affect the assessment of the cognitive function of the patient; 4. Having severe liver and renal diseases, or any other systemic diseases; 5. Being participating at the same time in a different clinical trial.

Design outcomes

Secondary

MeasureTime frame
Hamilton Anxiety Rating Scale (HAM-A);Hamilton Depression Rating Scale (HAMD);Zarit burden interview;

Primary

MeasureTime frame
National Institutes of Health Stroke Scale (NIHSS);Mini-Mental State Examination (MMSE);Montreal Cognitive Assessment (MoCA);

Countries

China

Contacts

Public ContactYihong Zhan

Xiamen University

yihongzhan31@163.com+86 136000938842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026